Track topics on Twitter Track topics that are important to you
This study investigated whether namilumab, a granulocyte-macrophage colony-stimulating factor inhibitor, might improve outcomes in patients with moderate or severe plaque psoriasis.
The British Journal of Dermatology
Original Article: GM-CSF as a Therapeutic Target in PsoriasisNEXT ARTICLE
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...